Connor, Clark & Lunn Investment Management (CC&L)
OPK icon

Connor, Clark & Lunn Investment Management (CC&L)’s Opko Health OPK Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618K Sell
412,051
-110,855
-21% -$141K ﹤0.01% 1327
2026
Q1 		$596K Buy
522,906
+92,276
+21% +$114K ﹤0.01% 1280
2025
Q4 		$543K Buy
430,630
+37,869
+10% +$52.7K ﹤0.01% 1287
2025
Q3 		$609K Buy
392,761
+1,097
+0.3% +$1.51K ﹤0.01% 1207
2025
Q2 		$517K Buy
391,664
+190,319
+95% +$260K ﹤0.01% 1248
2025
Q1 		$334K Buy
201,345
+179,045
+803% +$295K ﹤0.01% 1233
2024
Q4 		$32.8K Buy
+22,300
New +$34.1K ﹤0.01% 1380
2024
Q1 		– Sell
-1,538,716
Closed -$2.32M – 1667
2023
Q4 		$2.32M Buy
1,538,716
+118,759
+8% +$172K 0.01% 631
2023
Q3 		$2.27M Buy
1,419,957
+327,836
+30% +$597K 0.01% 583
2023
Q2 		$2.37M Buy
1,092,121
+201,691
+23% +$316K 0.01% 569
2023
Q1 		$1.3M Buy
890,430
+71,806
+9% +$92.4K 0.01% 653
2022
Q4 		$1.02M Buy
818,624
+61,384
+8% +$96.7K 0.01% 699
2022
Q3 		$1.43M Buy
757,240
+232,618
+44% +$550K 0.01% 574
2022
Q2 		$1.33M Buy
+524,622
New +$1.53M 0.01% 560
2022
Q1 		– Sell
-627,454
Closed -$3.02M – 1163
2021
Q4 		$3.02M Sell
627,454
-361,676
-37% -$1.46M 0.01% 441
2021
Q3 		$3.61M Buy
989,130
+187,633
+23% +$698K 0.02% 407
2021
Q2 		$3.25M Buy
801,497
+681,672
+569% +$2.67M 0.02% 448
2021
Q1 		$514K Buy
+119,825
New +$572K ﹤0.01% 791
2020
Q2 		– Sell
-628,827
Closed -$843K – 1140
2020
Q1 		$843K Sell
628,827
-13,181
-2% -$20.7K 0.01% 596
2019
Q4 		$944K Sell
642,008
-122,327
-16% -$205K 0.01% 556
2019
Q3 		$1.6M Buy
764,335
+61,600
+9% +$126K 0.01% 456
2019
Q2 		$1.72M Buy
702,735
+62,733
+10% +$137K 0.01% 464
2019
Q1 		$1.67M Sell
640,002
-101,239
-14% -$307K 0.01% 447
2018
Q4 		$2.23M Buy
741,241
+242,345
+49% +$822K 0.02% 395
2018
Q3 		$1.73M Buy
498,896
+288,114
+137% +$1.53M 0.01% 464
2018
Q2 		$991K Buy
210,782
+38,057
+22% +$144K 0.01% 616
2018
Q1 		$548K Buy
+172,725
New +$695K ﹤0.01% 558

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s OPK Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Opko Health (OPK) stake by 21% in Q2 2026, selling an estimated $141K and leaving 412,051 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OPK in Q1 2018 and has held it in 27 quarters since. The position peaked at $3.61M in Q3 2021. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 412,051 shares of Opko Health worth $618K as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 110,855 Opko Health shares in Q2 2026, an estimated $141K.
  • Opko Health made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1327 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Opko Health in Q1 2018 and has held it in 27 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Opko Health position peaked at $3.61M in Q3 2021.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.